Background-Conduction. Survival analyses and inherent log-rank tests showed that LBBB was not associated with higher all-cause mortality, cardiac mortality, or hospitalization for heart failure at 30 days or 1 year. At 30 days, but not at 1 year, group A had a significantly higher rate of pacemaker implantation. Conclusions-In this registry of high-volume centers, persistent LBBB after CoreValve Revalving System transcatheter aortic valve implantation showed no effect on hard end points. On the other hand, LBBB was associated with a higher short-term rate of pacemaker implantation. (Circulation. 2013;127:1300-1307.)Key Words: aortic valve ■ bioprosthesis ■ cardiac pacemaker, artificial ■ left bundle-branch block ■ prognosis